Baxter International Inc. · NYSE:BAX
Baxter International — Investor Day (May 2022)
12 slides from Baxter International's investor day presentation, May 25, 2022
Slide 1: Transform Baxter to Transform Healthcare
TRANSFORM BAXTER TO TRANSFORM HEALTHCARE GIUSEPPE ACCOGLI Executive VP and Chief Operating Officer 51
Slide 2: Forward-Looking Statements
Forward-Looking Statements The presentations being made on May 25, 2022 include forward-looking statements concerning Baxter’s financial results, R&D pipeline, including planned product launches (many of which are subject to regulatory approval and may require additional investment) and results of c
Slide 3: Accelerating Our Transformation To Deliver Better Outcomes
Accelerating Our Transformation To Deliver Better Outcomes Mission: To save and sustain lives Vision: Transform healthcare with customer focus: improve patient outcomes, enhance workflow efficiency and enable cost-effective care Strategic Value Innovation Market Operational Capital Creation Drivers:
Slide 4: Transforming Baxter To Transform Healthcare
Transforming Baxter To Transform Healthcare Vision: Transform healthcare with customer focus: improve patient outcomes, enhance workflow efficiency and enable cost-effective care • Prioritizing investment in higher growth categories • Investing in underpenetrated therapies Portfolio Management • Exe
Slide 5: Prioritizing High Growth Categories To Increase Baxter's WAMGR
Prioritizing High Growth Categories To Portfolio Increase Baxter’s WAMGR Management Baxter Sales (% Of Total) Market Growth Categories Management Approach Care Communications, • Increasing investment in R&D High Growth Connected Monitoring, CRRT, Drug Compounding, • Investing in market development C
Slide 6: Connecting The Journey Across the Care Continuum
Connecting The Journey Across the Care Continuum Site of Care Expansion Legacy Baxter 2022 - 2025 2026+ Presence • Expand breadth of portfolio offering (Med Hospital Targeting improved patient Strong Surg, Critical, Surgical) Care outcomes and lower cost of • Execute targeted geographic expansion he
Slide 7: Leveraging Innovation Legacy With Combined Connected Care Portfolio
Leveraging Innovation Legacy With Combined Connected Care Acceleration Connected Care Portfolio Legacy Baxter Post-Hillrom Acquisition 2022 - 2025 ~700K “Smart” Devices ~2M “Smart” Devices Building Upon Connected Care Portfolio • Increased installed base of “smart” devices focused on improving patie
Slide 8: Entering New Business Models With Profitable Recurring Revenue Opportunities
Entering New Business Models With Profitable Connected Care Acceleration Recurring Revenue Opportunities From Products To Products & Digital Solutions PD Cyclers • Sharesource connectivity Creating efficiency within the • Visualization and analytics healthcare system through streamlined communicat
Slide 9: Advancing Fluid Management With Connected Care
Advancing Fluid Management With Connected Care Connected Care Acceleration Near Term Medium Term Aspiration Strive for improved patient Time saved for Med Surg nurses Additional time saved through outcomes driven by ecosystem of through remote monitoring of bi-directional communication with connecte
Slide 10: Delivering Incremental Value With Hillrom Revenue Synergies
Delivering Incremental Value With Hillrom Revenue Synergies Anticipated Hillrom Revenue Synergies By 2025 (% Of Total) Accelerating Combined Company Growth: Channel Expansion ~50% • Execute on channel optimization and cross selling opportunities Geographic Expansion ~25% • Launch existing products i
Slide 11: One Baxter Strategy Summary
One Baxter Strategy Summary Portfolio Management • Entering and prioritizing investment in high growth categories • Investing in underpenetrated therapies • Strategic M&A Connected Care Acceleration 5%+ • Call upon Baxter’s history in the hospital setting and broad installed base • Increase value pr
Slide 12: Baxter 2022 Investor Conference
Baxter 2022 Investor Conference Wigs ee,